Concorde Asset Management, LLC Pet Iq, Inc. Transaction History

Concorde Asset Management, LLC

  • $173 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 30, 2020
SELL
$22.24 - $27.56 $441,730 - $547,396
-19,862 Closed
0 $0
Q3 2019

Oct 28, 2019
SELL
$25.56 - $36.1 $72,769 - $102,776
-2,847 Reduced 12.54%
19,862 $541,000
Q2 2019

Aug 08, 2019
BUY
$24.79 - $32.96 $2,578 - $3,427
104 Added 0.46%
22,709 $748,000
Q1 2019

May 01, 2019
BUY
$23.31 - $31.41 $526,922 - $710,023
22,605 New
22,605 $710,000

Others Institutions Holding PETQ

# of Institutions
189
Shares Held
30M
Call Options Held
81K
Put Options Held
113K
View Full List

About PetIQ, Inc.

PETQ Quotes by TradingView
  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track Concorde Asset Management, LLC Portfolio

Follow Concorde Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concorde Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concorde Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email